Safety and tolerability of MEDI9314 as single ascending dose in healthy subjects

Trial Identifier:	D4361C00002
Sponsor:	MedImmune, LLC
NCTID::	NCT02669667
Start Date:	February 2016
Primary Completion Date:	November 2016
Study Completion Date:	June 2017
Condition:	Healthy Volunteers; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English translation
	Japanese translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ
United States of America, CA	Glendale, CA, United States of America, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company